Aprecia’s Spritam- becomes first anti-epilepsy pill manufactured with 3D printer to get the US Food and Drug Administration (USFDA) approval. The pill will be launched in Market by 2016. Structure of the pill ‘Spritam’ was developed by using ZipDose 3D printing technology by Aprecia Pharmaceuticals.It is a pill that dissolve faster and delivers up to 1000 mg of medication in a single dose.
Points to Remember:
- Pill will Minimise the costing of designing and creating complex structure in lesser time.
- This pill will improve the medications.
- It will have a proptionate amount of content to the children and the elders.
- It will open endless possibilities of personalised medications.
ZipDose 3D printing technology
Aprecia is the first and only company in the world utilizing this cutting-edge 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale.
The 3DP-based ZipDose Technology platform does not rely on compression forces or molding technique
Benefits from ZipDose technology:
- Patients can experience a rapidly disintegrating, taste-masked, and convenient way to take or administer medicine.
- Patients can experience a rapidly disintegrating, taste-masked, and convenient way to take or administer medicine
About Aprecia
- Aprecia is a specialty pharmaceutical company that’s committed to enhancing customers’ experience with highly prescribed high-dose medications.
- Aprecia is the first and only company in the world utilizing this cutting-edge 3DP technology platform to develop and manufacture pharmaceutical products on a commercial scale.
